trimebutine has been researched along with Erythema Multiforme in 1 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacq, Y | 1 |
| Vaillant, L | 1 |
| Monegier du Sorbier, C | 1 |
| Dorval, ED | 1 |
| Certin, M | 1 |
| Metman, EH | 1 |
1 other study available for trimebutine and Erythema Multiforme
| Article | Year |
|---|---|
[Severe erythema multiforme and hepatitis during treatment with trimebutine].
Topics: Adult; Benzoates; Chemical and Drug Induced Liver Injury; Erythema Multiforme; Female; Humans; Trime | 1989 |